There are no studies available concerning valproate associated weight gain and associated epigenetic changes, but since valproate interferes with the recruitment of MeCP2 there may be a relationship between epigenetic changes and valproate induced obesity. Here, MECP2 is linked to obesity due to melanocortin 4 receptor deficiency.